Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-25 · accession 0001415889-24-009046 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | 2024-03-25 | MIRM | Radovich Peter | Pres AND COO | S - Sale | $25.80 | -4,303 | 29.0K | -13% | -$111.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-25 | S | D | 4,303 | $25.80 | 29,013 | D | — | — | (F1) The weighted average sale price for the transaction reported was $25.80, and the range of prices were between $25.80 and $25.825. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |